INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | -22.6% | 7,381 | 0.0% | 0.01% | -13.3% |
| Q2 2023 | $301 | +2.4% | 7,381 | -6.3% | 0.02% | +15.4% |
| Q1 2023 | $294 | +7.3% | 7,881 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $274 | -99.9% | 7,859 | -0.2% | 0.01% | -38.1% |
| Q3 2022 | $441,000 | +8.1% | 7,872 | -0.3% | 0.02% | +16.7% |
| Q2 2022 | $408,000 | -28.9% | 7,894 | 0.0% | 0.02% | -21.7% |
| Q1 2022 | $574,000 | -38.5% | 7,894 | -0.1% | 0.02% | -20.7% |
| Q4 2021 | $933,000 | -17.4% | 7,898 | -6.1% | 0.03% | -19.4% |
| Q3 2021 | $1,129,000 | +88.8% | 8,412 | +127.7% | 0.04% | +80.0% |
| Q2 2021 | $598,000 | +564.4% | 3,694 | -42.4% | 0.02% | +900.0% |
| Q1 2017 | $90,000 | -24.4% | 6,412 | -29.4% | 0.00% | -33.3% |
| Q4 2016 | $119,000 | -25.2% | 9,077 | -2.9% | 0.00% | -40.0% |
| Q3 2016 | $159,000 | – | 9,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |